DRUG NEWS: Newer drug outperforms tamoxifen

February 2005 
Volume 35  Number 2
Pages 30 - 30
  PDF Version Available!


  • Source

    Based on results of a major new study, anastrozole (Arimidex) should replace tamoxifen as the drug of choice for preventing recurrent breast cancer in postmenopausal women with early, localized hormone-receptor-positive breast cancer. Researchers found that anastrozole may prevent 70% to 80% of the most common breast cancer tumors that occur in postmenopausal women, compared with 50% for tamoxifen.

    The study involved more than 9,000 women in over 20 countries who were treated for early-stage breast cancer. Compared with women taking tamoxifen for 5 years, those who took anastrozole for the same length of time were less likely to have their cancer recur, develop in the other breast, or metastasize. In general, anastrozole caused fewer adverse reactions than tamoxifen, especially gynecologic problems and vascular events, although arthralgia and fractures were more common with anastrozole.

    Anastrozole is one of three newer ...

Purchase Now !

To purchase this item, follow the instructions below. If you’re not already logged in, be sure to enter your login information below to ensure that your item is saved to your File Drawer after you purchase it.

Not a member? Join now for Free!

1) If you're not already logged in, enter your information below to save this item in your File Drawer for future viewing.

User name:


Forgot your user name or password?
2)  If you have a coupon or promotional code, enter it
here.(If not, just click Continue.

Digital Coupon: (optional)

3)  Click Continue to go to the next screen, where
you'll enter your payment details.

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events